We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Genetic Origin of Lipid Disorders

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2006 by University of Oslo.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00277121
First Posted: January 13, 2006
Last Update Posted: January 13, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Lipid Clinic, The National Hospital, Oslo, Norway
Research Institute of Internal Medicine, The National Hospital, Oslo, Norway
Ullevaal University Hospital
Norwegian Institute of Public Health
Hormone Laboratory, Aker University Hospital, Oslo, Norway
CIGENE, Agricultural University of Norway, Aas, Norway
Information provided by:
University of Oslo
  Purpose
Several lipid disorders are without known genetic origin. The scope of this project is to sequence genes superior involved in lipid and carbohydrate metabolism in patients with severe lipid disorders. The resulting mutations will be tested in suitable in vitro systems to detect their part in development of the specific disease.

Condition Phase
Lipid Disorder Phase 1

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective/Prospective
Official Title: Genetic Origin of Lipid Disorders

Resource links provided by NLM:


Further study details as provided by University of Oslo:

Study Start Date: January 2006
Detailed Description:
See "brief summary" above.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 54 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • proven written informed consent prior to recruitment
  • male or female
  • 18-55 years old
  • patients with severe lipid disorders
  • fasting plasma cholesterol, triglyceride or glucose, blood pressure or waist circumference/BMI out of normal range

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00277121


Contacts
Contact: Hilde Irene Nebb, PhD +47-22851510 h.i.nebb@medisin.uio.no
Contact: Kjetil Retterstøl, Dr Med +47-23075603 kjetil.retterstol@rikshospitalet.no

Locations
Norway
Department of Nutrition, University of Oslo Not yet recruiting
Oslo, Norway, NO-0316
Sponsors and Collaborators
University of Oslo
Lipid Clinic, The National Hospital, Oslo, Norway
Research Institute of Internal Medicine, The National Hospital, Oslo, Norway
Ullevaal University Hospital
Norwegian Institute of Public Health
Hormone Laboratory, Aker University Hospital, Oslo, Norway
CIGENE, Agricultural University of Norway, Aas, Norway
Investigators
Study Chair: Hilde I Nebb, PhD Department of Nutrition, University of Oslo
Principal Investigator: Karianne Solaas, PhD Department of Nutrition, University of Oslo
Principal Investigator: Monica H Carlsen Department of Nutrition, University of Oslo
Principal Investigator: Leiv Ose, Dr med Lipid Clinic, The National Hospital
Principal Investigator: Marit S Nenseter, PhD Research Institute of Internal Medicine, The National Hospital
Principal Investigator: Kirsten Holven, PhD Research Institute of Internal Medicine, The National Hospital
Principal Investigator: Bente Halvorsen, PhD Research Institute of Internal Medicine, The National Hospital
Principal Investigator: Serena Tonstad, Dr med Department of Preventive Medicine, Ullevål university hospital
Principal Investigator: Håkon Gjessing, PhD Norwegian Institute of Public Health
Principal Investigator: Per Thorsby, Dr med Hormone laboratory, Aker university hospital
Principal Investigator: Sigbjørn Lien, PhD Agricultural university of Norway
Principal Investigator: Paul Berg, PhD Agricultural university of Norway
Principal Investigator: Kjetil Retterstøl, Dr med Lipid Clinic, The National Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00277121     History of Changes
Other Study ID Numbers: S-03150 (REK)
02/4746 (SHdir)
10163 (NSD)
First Submitted: January 12, 2006
First Posted: January 13, 2006
Last Update Posted: January 13, 2006
Last Verified: January 2006

Keywords provided by University of Oslo:
Lipid disorder
Gene mutation

Additional relevant MeSH terms:
Disease
Lipid Metabolism Disorders
Pathologic Processes
Metabolic Diseases